{"schema_version":"1","generated_at":"2026-10-31T08:48:46.932Z","data_as_of":null,"url":"https://www.findmykol.com/kol/alexander-raufi","json_url":"https://www.findmykol.com/kol/alexander-raufi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"alexander-raufi","name":"Alexander Raufi","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Brown University","institution_url":"https://www.findmykol.com/institution/brown-university","city":"Providence","state":"RI","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1124461181","orcid":"0000-0001-5645-2629","openalex":"A5050792634"},"summary":"Alexander Raufi is an Oncology physician affiliated with Brown University. OpenAlex indexes 80 publications with 1,053 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":80,"cited_by_count":1053,"h_index":14,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05630794","title":"Testing for Safety and Colorectal Cancer Preventive Effects of ONC201","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT05630794","trial_url":"https://www.findmykol.com/trial/NCT05630794"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":134.99,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1124461181"},{"payer":"AstraZeneca UK Limited","program_year":2025,"amount_usd":100,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1124461181"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":44.98,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1124461181"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1124461181","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":32,"classes_total":2,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":22.7,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":39},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":9.3,"drugs":[{"name":"Omeprazole","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":31.2,"classes_total":3,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":19.4,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":37},{"class":"Other antidepressants","setting":"prescribed","share_pct":7.3,"drugs":[{"name":"Mirtazapine","share_pct":100}],"max_beneficiaries":12}]},{"area":"Sensory organs","share_pct":30.4,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":30.4,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":29}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":96.8,"facility_pct":3.2},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO","year":2026,"journal":"JCO Precision Oncology","source_url":"https://doi.org/10.1200/po-26-00138","status":"verified"},{"title":"METEORITE: A phase II study of Y-90, capecitabine, and atezolizumab in oligometastatic CRC (BrUOG430).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.2_suppl.tps276","status":"verified"},{"title":"Acquired resistance to molecularly targeted therapies for cancer","year":2025,"journal":"Cancer Drug Resistance","source_url":"https://doi.org/10.20517/cdr.2024.189","status":"verified"},{"title":"Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma","year":2025,"journal":"Nature Genetics","source_url":"https://doi.org/10.1038/s41588-025-02345-5","status":"verified"},{"title":"Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer","year":2025,"journal":"ESMO Open","source_url":"https://doi.org/10.1016/j.esmoop.2025.105122","status":"verified"}],"source":"works"},"contact":{"address_1":"593 EDDY ST","city":"Providence","state":"RI","zip":"02903","phone":"401-444-5435","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1124461181","source":"identity"},"similar":[{"name":"James Klinger","slug":"james-klinger","institution":"Brown University","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/james-klinger","json_url":"https://www.findmykol.com/kol/james-klinger/profile.json"},{"name":"Noah Philip","slug":"noah-philip","institution":"Brown University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/noah-philip","json_url":"https://www.findmykol.com/kol/noah-philip/profile.json"},{"name":"Sharon Rounds","slug":"sharon-rounds","institution":"Brown University","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/sharon-rounds","json_url":"https://www.findmykol.com/kol/sharon-rounds/profile.json"},{"name":"William Corrao","slug":"william-corrao","institution":"Brown University","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/william-corrao","json_url":"https://www.findmykol.com/kol/william-corrao/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2019-04-02","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}